Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis

BACKGROUND: Sorafenib is used in patients with intermediate or advanced stage hepatocellular carcinoma (HCC) before or after of transarterial chemoembolization (TACE). However, the survival outcomes of TACE combined with sorafenib versus TACE alone remain controversial. Thus, we conducted a meta-ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Leida, Hu, Peng, Chen, Xi, Bie, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063775/
https://www.ncbi.nlm.nih.gov/pubmed/24945380
http://dx.doi.org/10.1371/journal.pone.0100305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063775/
https://www.ncbi.nlm.nih.gov/pubmed/24945380
http://dx.doi.org/10.1371/journal.pone.0100305

Ejemplares similares